A61L27/46

JAB1 Inhibitory Compositions for Ossification and Methods Related Thereto
20220023506 · 2022-01-27 ·

This disclosure relates to compounds and compositions for forming bone and methods related thereto. In certain embodiments, the disclosure relates to methods of forming bone comprising implanting a bone graft composition comprising a growth factor such as BMP in a subject at a site of desired bone growth or enhancement in combination with a JAB1 blocker.

JAB1 Inhibitory Compositions for Ossification and Methods Related Thereto
20220023506 · 2022-01-27 ·

This disclosure relates to compounds and compositions for forming bone and methods related thereto. In certain embodiments, the disclosure relates to methods of forming bone comprising implanting a bone graft composition comprising a growth factor such as BMP in a subject at a site of desired bone growth or enhancement in combination with a JAB1 blocker.

JAB1 Inhibitory Compositions for Ossification and Methods Related Thereto
20220023506 · 2022-01-27 ·

This disclosure relates to compounds and compositions for forming bone and methods related thereto. In certain embodiments, the disclosure relates to methods of forming bone comprising implanting a bone graft composition comprising a growth factor such as BMP in a subject at a site of desired bone growth or enhancement in combination with a JAB1 blocker.

COMPOSITIONS AND METHODS FOR REGENERATION OF BONE TISSUE
20220023493 · 2022-01-27 ·

Embodiments of the disclosure relate to compositions that stimulate the generation or regeneration of bone tissue, increasing the rate of bone healing or repair inducing the formation of osteoblasts, inducing the differentiation of mesenchymal stem cells, and the treatment of a disease or disorder in a subject.

COMPOSITIONS AND METHODS FOR REGENERATION OF BONE TISSUE
20220023493 · 2022-01-27 ·

Embodiments of the disclosure relate to compositions that stimulate the generation or regeneration of bone tissue, increasing the rate of bone healing or repair inducing the formation of osteoblasts, inducing the differentiation of mesenchymal stem cells, and the treatment of a disease or disorder in a subject.

COMPRESSION RESISTANT IMPLANTS INCLUDING AN OXYSTEROL AND METHODS OF USE

Provided is a compression resistant implant configured to fit at or near a bone defect to promote bone growth, the compression resistant implant comprising porous ceramic particles in a biodegradable polymer, and an oxysterol disposed in or on the compression resistant implant. Methods of making and use are further provided.

COMPRESSION RESISTANT IMPLANTS INCLUDING AN OXYSTEROL AND METHODS OF USE

Provided is a compression resistant implant configured to fit at or near a bone defect to promote bone growth, the compression resistant implant comprising porous ceramic particles in a biodegradable polymer, and an oxysterol disposed in or on the compression resistant implant. Methods of making and use are further provided.

COMPRESSION RESISTANT IMPLANTS INCLUDING AN OXYSTEROL AND METHODS OF USE

Provided is a compression resistant implant configured to fit at or near a bone defect to promote bone growth, the compression resistant implant comprising porous ceramic particles in a biodegradable polymer, and an oxysterol disposed in or on the compression resistant implant. Methods of making and use are further provided.

METHOD FOR PRODUCING A MATERIAL FOR A BONE IMPLANT
20210338896 · 2021-11-04 ·

A material for a bone implant contains: (a) a carrier structure having a surface that has at least one biocompatible material; (b) a matrix covalently bound to the surface; and (c) calcium phosphate embedded in the matrix. A medically acceptable, highly compatible and versatile material can be provided, if the matrix has at least one polysaccharide.

METHOD FOR PRODUCING A MATERIAL FOR A BONE IMPLANT
20210338896 · 2021-11-04 ·

A material for a bone implant contains: (a) a carrier structure having a surface that has at least one biocompatible material; (b) a matrix covalently bound to the surface; and (c) calcium phosphate embedded in the matrix. A medically acceptable, highly compatible and versatile material can be provided, if the matrix has at least one polysaccharide.